Список литературы (глава 1)

1. AR Carmichael, Obesity as a risk factor for development and poor prognosis of breast cancer, An International Journal of Obstetrics&Gynaecology , volume 113, Issue 10, pages 1160–1166

2.

La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, et al., Body mass index and post-menopausal breast cancer: an age-specific analysis, Br J Cancer 1997; 75: 441–4.

3. Petrelli JM, Calle EE, Rodriguez C, Thun MJ.,Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women . Cancer Causes Control 2002; 13 : 325—32.

4. Lahmann PH, Lissner L, Berglund G. Breast cancer risk in overweight postmenopausal women , Cancer Epidemiol Biomarkers Prev 2004 ; 13: 1414.

5. Chlebowski RT, Aiello E, McTiernan A. “ Weight loss in breast cancer patient management” J Clin Oncol 2002;20 : 1128—43.

6. Enger SM, Greif JM, Polikoff J, Press M. Body weight correlates with mortality in early-stage breast cancer. Arch Surg 2004; 139 : 954—8.

7. McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors . J Clin Oncol 2003; 21 : 1961—6.

8. Stephenson GD, Rose DP. Breast cancer and obesity: an update . Nutr Cancer 2003;45:1–16.

9. Stoll BA. Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated? Breast Cancer Res Treat 1996; 38: 239–46.

10. Bruning PF. Endogenous estrogens and breast cancer a possible relationship between body fat distribution and estrogen availability. J Steroid Biochem 1987; 27: 487–92.

11. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer Gut 2013; 62: 6 933–947

12. Akiyoshi T, Ueno M, Fukunaga Y, et al. Effect of body mass index on short-term outcomes of patients undergoing laparoscopic resection for colorectal cancer: a single institution experience in Japan. Surg Laparosc Endosc Percutan Tech 2011; 21: 409–14.

13. Singh A, Muthukumarasamy G, Pawa N, et al. Laparoscopic colorectal cancer surgery in obese patients. Colorectal Dis 2011; 13: 878–83.

14. Simkens LH, Koopman M, Mol L, et al. Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. Eur J Cancer 2011; 47: 2560–7.

15. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86: s 836–42.

16. LeRoith D, Roberts CT Jr . The insulin-like growth factor system and cancer. Cancer Lett 2003; 195: 127–37.

17. Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 2011; 3: 12.

18. Pearson JR, Gill CI, Rowland IR. Diet, fecal water, and colon cancer– development of a biomarker. Nutr Rev 2009; 67: 509–26.

19. Nagengast FM, Grubben MJ, van Munster IP. Role of bile acids in colorectal carcinogenesis . Eur J Cancer. 1995 Jul-Aug; 31A(7–8): 1067–70.

20. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991; 87: 237–46.

21. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140: 1807–16.

22. Cani PD, Osto M, Geurts L, et al . Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity . Gut Microbes 2012; 3: 279–88.

23. DiBaise JK, Zhang H, Crowell MD, et al . Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008; 83: 460–9.

25. Ildaphonse G, George PS, Mathew A., Obesity and kidney cancer risk in men: a meta-analysis. Asian Pac J Cancer Prev. 2009 Apr-Jun; 10(2): 279–86.

26. Bergstrom A1, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A. Obesity and renal cell cancer – a quantitative review. Br J Cancer. 2001 Sep 28;85(7):984-90.

27. Gui-Ming Zhang, Yao Zhu and Ding-Wei Ye. Metabolic syndrome and renal cell carcinoma. World J Surg Oncol. 2014 Jul 29; 12(1): 236.

28. Häggstrom C, Rapp K, Stocks T, Manjer J, Bjorge T, Ulmer H, Engeland A, Almqvist M, Concin H, Selmer R, Ljungberg B, Tretli S, Nagel G, Hallmans G, Jonsson H, Stattin P. Metabolic factors associated with risk of renal cell carcinoma . PLoS One. 2013;8(2):e57475.

29. Park J, Morley TS, Kim M, Clegg DJ, Scherer PE, Obesity and cancer-mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014 Aug; 10(8): 455–65.

30. Otunctemur A, Ozbek E, Sahin S, Dursun M, Besiroglu H, Koklu I, Erkoc M, Danis E, Bozkurt M, Gurbuz A. Diabetes mellitus as a risk factor for high grade renal cell carcinoma. Asian Pac J Cancer Prev. 2014; 15(9): 3993–6.

31. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013; 2013: 291546. doi: 10.1155/2013/291546. Epub 2013 Aug 29.

32. Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549–5.

33. 4. Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus . Gut 2008; 57: 173–80.

34. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications . Ann Intern Med 2005; 143: 199–211

35. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 872–8

36. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011; 8: 340–7.

37. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006; 354: 2340–8.

38. Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008; 17: 352–8.

39. Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 2005 ; 16: 285–94.

40. Ogunwobi OO, Beales IL. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor . Br J Biomed Sci 2008 ; 65: 121–7.

41. Brochu-Gaudreau K, Rehfeldt C, Blouin R, et al. Adiponectin action from head to toe. Endocrine 2010; 37: 11–32.

42. Armstrong RW, Borman B. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978–1992. Int J Epidemiol 1996; 25: 941–7.

43. Lepage C, Rachet B, Jooste V, et al. Continuing rapid increase in esophageal adenocarcinoma in England and Wales . Am J Gastroenterol 2008; 103: 2694–9

44. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age . J Natl Cancer Inst 2008; 100: 1184–7.

45. Clegg DJ, Brown LM, Woods SC, et al. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006; 55: 978–87.

46. Quinton ND, Smith RF, Clayton PE, et al. Leptin binding activity changes with age: the link between leptin and puberty . J Clin Endocrinol Metab 1999.

47. Asarian L, Geary N. Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats. Horm Behav 2002; 42: 461–71.

48. Howard JM, Beddy P, Ennis D, et al. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg 2010; 97: 1020–7.

49. Quinton ND, Laird SM, Okon MA, et al. Serum leptin levels during the menstrual cycle of healthy fertile women. Br J Biomed Sci 1999; 56: 16–9.

50. Ainslie DA, Morris MJ, Wittert G, et al. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y . Int J Obes Relat Metab Disord 2001; 25: 1680–8.

51. Edelstein ZR, Farrow DC, Bronner MP, et al. Central adiposity and risk of Barrett’s esophagus. Gastroenterology 2007 ; 133: 403–11.

52. Lagergren J, Nyren O. Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 1998; 7: 913–5.

53. Rudolf Kaaks, Annekatrin Lukanova and Mindy S. Kurzer Obesity, Endogenous Hormones and Endometrial Cancer, Cancer Epidemiol Biomarkers Prev 2002; 11: 1531–1543.

54. Frederic Amant, Philippe Moerman, Prof Patrick Neven, Dirk Timmerman, Erik Van Limbergen, Ignace Vergote. Endometrial cancer , The Lancet : volume 366, Issue 9484, 6–12 August 2005, Pages 491–505.

55. Luigino Dal Maso, Livia S. A. Augustin, Aspasia Karalis, Renato Talamini, Silvia Franceschi, Dimitrios Trichopoulos, Christos S. Mantzoros, and Carlo La Vecchia. Circulating Adiponectin and Endometrial Cancer Risk , JCEM : Volume 89 Issue 3 – March 1, 2004.

56. MacInnis RJ. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis . Cancer Causes Control 2006; 17: 989–1003.

57. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 63–9.

58. Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality . Cancer 2007; 109: 675–84.

59. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial . Cancer Epidemiol Biomarkers Prev 2006; 15: 1977–83.

60. Yin Cao1, Jing Ma2. Body Mass Index, Prostate Cancer – Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis . Cancer Prev Res April 2011 4; 486.

61. Jemal A, Siegel R, Ward E, et al. Cancer statistics , 2007. CA Cancer J Clin 2007; 57: 43–66.

62. Nelson WG, De Marzo AM, Isaacs WB.

Prostate cancer . N Engl J Med 2003; 349: 366–81.

63. Andersson SO, Wolk A, Bergstrom R, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers . J Natl Cancer Inst 1997; 89:385–9.

64. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579–91.

65. Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991; 40: 101–4.

66. Brakenhielm E, Veitonmaki N, Cao R, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis . Proc Natl Acad Sci U S A 2004; 101: 2476–81.

67. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA. 1995; 273: 1605–1609.

68. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health – AARP Diet and Health Cohort. Am J Epidemiol . 2008; 167(5): 586–597.

69. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large US cohort. Cancer Epidemiol Biomarkers Prev . 2005; 14(2): 459–466.

70. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer . 2007; 120(9): 1993–1998.

71. Donghui Li, PhD; Jeffrey S. Morris, PhD; Jun Liu, MS; Manal M. Hassan, MD, PhD; R. Sue Day, PhD; Melissa L. Bondy, PhD; James L. Abbruzzese, MD. Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer. JAMA. 2009; 301(24): 2553–2562.

72. S C Larsson and A Wolk. Obesity and the risk of gallbladder cancer: a meta-analysis, British Journal of Cancer (2007) 96, 1457–1461.

73. Zatonski W, La Vecchia C, Levi F, Negri E, Lucchini F. Descriptive epidemiology of gall-bladder cancer in Europe . J Cancer Res Clin Oncol 1993; 119: 165—71.

74. Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, Jain M, Przewozniak K, Baghurst P, Moerman CJ, Simard A, Howe GR, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer . J Natl Cancer Inst 1997; 89: 1132—8.

75. Purslow LR, Sandhu MS, Forouhi N, et al. Energy Intake at Breakfast and Weight Change: Prospective Study of 6,764 Middle-aged Men and Women. Am J Epidemiol 2007; Dec 12

76. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

77. Vanni E, Bugianesi E, Kotronen A et al. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010; 42: 320–330.

78. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease . JAMA 2002 ; 287: 2414–2423.

79. Augustin LS, Franceschi S, Jenkins DJ et al. Glycemic index in chronic disease: a review. Eur J Clin Nutr 2002; 56: 1049–1071.

80. Saunders D, Seidel D, Allison M et al. Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidence . Aliment pharmacol Ther 2010; 31: 1051–1063.

81. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies . Br J Cancer 2007; 97: 1005–1008.

82. WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective . Washington, DC: AICR 2007.

83. Schlesinger S, Aleksandrova K, Pischon T et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 2012; doi: 10.1002/ijc.27645.

84. Ren HB, Yu T, Liu C et al. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis . Cancer Causes Control 2011; 22: 837–847.

85. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence . Clin Gastroenterol Hepatol 2006; 4: 369–380.

86. Aleksandrova K, Pischon T, Buijsse B, May AM, Peeters PH, Bueno-de-Mesquita HB, Jenab M, Fedirko V, Dahm CC, Siersema PD, Freisling H, Ferrari P, Overvad K, Tjonneland A, Trichopoulou A, Lagiou P, Naska A, Pala V, Mattiello A, Ohlsson B, Jirstrom K, Key TJ, Khaw KT, Riboli E, Boeing H. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition . Eur J Cancer. 2013 Nov; 49(16): 3526–36. doi: 10.1016/j.ejca.2013.06.021. Epub 2013 Jul 15.

87. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanism of action and applicability to humans. Annu Rev Med 2003, 54: 131–152.

88. Dirx MJ, Zeegers MP, Dagnelie PC, van den Bogaard T, van den Brandt PA. Energy restriction and the risk of spontaneous mammary tumours in mice: a meta-analysis. Int J Cancer 2003, 106: 766–770.

89. Harvell DM, Strecker TE, Xie B, Pennington KL, McComb RD, Shull JD. Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat. Carcinogenesis 2002, 23: 161–169.

90. Matsuzaki J, Yamaji R, Kiyomya K, Kurebe M, Inui H, Nakano Y. Implanted tumor growth is suppressed and survival is prolonged in sixty percent of food-restricted mice . J Nutr 2000, 130: 11–115.

91. Michels KB, Ekbom A. Caloric restriction and incidence of breast cancer . Jama 2004, 291: 1226–1230.

92. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values:2002. Am J Clin Nutr 2002, 76:5–56.

93. Augustin LS, Gallus S, Negri E, La Vecchia C. Glycemic index, glycemic load and risk of gastric cancer. Ann Oncol 2004 , 15:581–584.

94. Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Jenkins DJ, Kendall CW, Maso L, Talamini R, La Vecchia C. Glycemic index and load and risk of upper-aerodigestive tract neoplasm. Cancer Causes Control 2003, 14: 657–662.

95. Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Franceschi S, Dal Maso L, Jenkins DJ, Kendall CW, La Vecchia C. Glycemic index and glycemic load in endometrial cancer . Int J Cancer 2003, 105: 404–407.

96. Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M, Boyle P, Jenkins DJ, La Vecchia C. Dietary glycemic load and colorectal cancer risk . Ann Oncol 2001, 12: 173–178.

97. Augustin LS, Polesel J, Bosetti C, Kendall CW, La Vecchia C, Parpinel M, Conti E, Montella M, Franceschi S, Jenkins DJ, Dal Maso L. Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann Oncol 2003, 14: 78–84.

98. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002, 11: 385–391.

99. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults . Am I Epidemiol 2004, 159: 1160–1169

100. La Vecchia C, Negri E, Decarli A, Franceschi S. Diabete mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997, 6: 1007–1010.

101. Sandhu MS, Luben R, Khaw KT. Self reported non-unsulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study . J Epidemiol Community Health 2001, 55: 804–805.

102. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, Lazovich D, Folsom AR. Diabetes and endometrial cancer in the Iowa women`s health study. Cancer Epidemiol Biomarkers Prev 2001, 10: 611–616.

103. Cale EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults . Cancer Causes Control 1998, 9: 403–410.

104. Finegold SM, Sutter VL, Sugihara PT, Elder HA, Lehmann SM, Phillips RL. Fecal microbial flora in Seventh Day Adventist Populations and control subjects . Am J Clin Nutr 1977; 30: 1781–1792.

105. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61: 3202–3207.

106. Goldin PR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984; 39: 756–761.

107. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group . Urol Int 1992; 49: 125–129.

108. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995; 27: 104–109.

109. Flint HJ. Nutr Rev 2012; 70 Suppl1: S10–S13 (World Cancer Report 2014 ).

110. Tremaroli V, Backhed F. Nature 2012; 489: 242–249 (World Cancer Report 2014 ).

111. Commane D, Hughes R, Shortt C, Rowland I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res /Fundam Mol Mech Mutagen 2005; 591: 276–89.

112. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, Kumar P, Poddar D, Aggarwal P, Henry C. Cancer-preventing attributes of probiotics: an update . Int J Food Sci Nutr 2010; 61: 473–96.

113. de Moreno de LeBlanc A, Perdigon G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc 2010; 69: 421–8.

114. Mohammadi R, Mortazavian AM. Review article: technological aspects of prebiotics in probiotic fermented milks. Food Rev Intl 2010; 27: 192–212.

115. Kumar M, Verna V, Nagpal R, Kumar A, Gautam SK, Behare PV, Grover CR, Aggarwal PK. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB-induced hepatocellular carcinoma . Gene 2011; 490: 54–9.

116. Karimi R, Motrazavian A, Da Cruz A. Viability of probiotic microorganisms in cheese during production and storage: a review. Dairy Sci Technol 2011; 91: 283–308.

117. Burns A, Rowland I. Anti-carcinogenicity of probiotics and prebiotics . Curr Isues Intest Microbiol , 2000; 1: 13–24.

Задать вопрос врачу онлайн
<< | >>
Источник: Гелена Беликова. Бойкот раку. Защитите себя и своих близких! Советы врача-онколога из Великобритании: Москва; 2016. 2016

Еще по теме Список литературы (глава 1):

  1. СПИСОК ЛИТЕРАТУРЫ
  2. СПИСОК ЛИТЕРАТУРЫ
  3. СПИСОК ЛИТЕРАТУРЫ[6]
  4. СПИСОК ЛИТЕРАТУРЫ
  5. Список литературы
  6. Список литературы
  7. Список литературы (глава 1)
  8. Список литературы (глава 2)
  9. Список литературы (глава 3)
  10. Список литературы (глава 4)
  11. Список литературы (глава 5)
  12. Список литературы (глава 6)
  13. Список литературы (глава 7)
  14. Список литературы (глава 8)
  15. Список литературы (глава 9)
  16. Список литературы (глава 10)
  17. Список литературы (глава 11)
  18. Список литературы (глава 12)
  19. СПИСОК ЛИТЕРАТУРЫ
  20. СПИСОК ЛИТЕРАТУРЫ
- Акушерство и гинекология - Анатомия - Биология - Болезни уха, горла и носа - Валеология - Ветеринария - Внутренние болезни - Восстановительная медицина - Гастроэнтерология и гепатология - Гематология - Геронтология, гериатрия - Гигиена и санэпидконтроль - Дерматология - Диетология - Здравоохранение - Иммунология и аллергология - Интенсивная терапия, анестезиология и реанимация - Инфекционные заболевания - Информационные технологии в медицине - История медицины - Кардиология - Клинические методы диагностики - Кожные и венерические болезни - Лучевая диагностика, лучевая терапия - Маммология - Медицина катастроф - Медицинская паразитология - Медицинская этика - Медицинские приборы - Медицинское право - Наследственные болезни - Неврология и нейрохирургия - Нефрология - Онкология - Организация системы здравоохранения - Оториноларингология - Офтальмология - Патофизиология - Педиатрия - Приборы медицинского назначения - Психиатрия - Психология - Пульмонология - Стоматология - Судебная медицина - Токсикология - Травматология - Фармакология и фармацевтика - Физиология - Фтизиатрия - Хирургия - Эмбриология и гистология - Эпидемиология -